Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boston Scientific
MedTech
Boston Scientific, Abbott tout long-term heart occluder data
Boston Scientific and Abbott both put forward studies supporting their respective implants for sealing off the heart’s left atrial appendage.
Conor Hale
Nov 19, 2024 12:00pm
Boston Scientific resumes Farapulse study in first-line afib
Nov 11, 2024 9:35am
Boston Scientific bolsters pulsed field ablation with Cortex buy
Nov 4, 2024 11:00am
TCT: Boston Scientific's TAVR implant fails head-to-head study
Oct 30, 2024 11:55am
Boston Scientific's CMO takes the pulse of pulsed field ablation
Oct 29, 2024 1:00pm
Boston Scientific posts 177% EP growth, pauses Farapulse study
Oct 23, 2024 11:58am
